Hi @jalan00. Just checking in with you to see how your dad is doing now that he’s gotten through his first cycle of Azacitidine and Venetoclax. These two medications are often used together and are particularly effective for older adults with AML who are not candidates for intensive chemotherapy.

Regarding the of Immunophenotypic Analysis, the information listed such as CD33, CD45, etc., are commonly expressed antigens for AML. Most of us with AML will have had similar testing with varying comments unique to our own cases. But since they are specific to each patient, this is information for your dad’s doctor to interpret.
The good news is that you mentioned he is negative for the FLT3 mutation, which was often the ‘problem child’ of mutations giving our doctors a challenge with treatment. There is a targeted drug for that mutation now which works well. I was able to use that in conjunction with chemo.

Even without NGS (next generation sequencing) available, your dad’s doctor seems very knowledgeable, has run sophisticated tests and is using first-line treatment for your dad’s AML. His doctor will be able to interpret the tests results and should be willing to discuss them with you.

From personal experience, it can be helpful to have the list of questions or concerns written down in a notepad or even your phone, so that you can go right down the list. It’s so easy during appointments to have conversations take a different direction and we forget important items we wanted to discuss. So having it written down helps to bring the focus back.

When is your dad’s next appointment to speak with his doctor? Has he had any bloodwork since his last cycle ended?